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Global health, definitions and descriptions 
Introduction
Sir Michael Marmot, who chaired the World Health 
Organization (WHO) Commission on Social 
Determinants of Health, has identified the need to 
seek “public policy based on a vision of the world 
where people matter and social justice is paramount” 
(Marmot, 2005, p. 1099). In this chapter, we ground 
this imperative in evidence of dramatic disparities in 
health status that are traceable, in large measure, to 
the globally unequal distribution of resources neces-
sary for health. We further outline the contours of an 
international economic and political order that often 
magnifies those inequalities, and conclude that the 
imperative of mobilizing resources to protect health on 
a much larger scale than at present is central to any glo-
bal health ethics worthy of the name.
“If living were a thing that money  
could buy”
Imagine for a moment a series of disasters that killed 
almost 1400 women every day for a year: the equivalent 
of four or five daily crashes of crowded long-distance 
airliners. There is little question that such a situation 
would quickly be regarded as a humanitarian emer-
gency, as the stuff of headlines, especially if ways of 
preventing the events were well known and widely 
practised in some parts of the world. However, remark-
ably little attention is paid outside the global health and 
human rights domains to complications of pregnancy 
and childbirth that kill more than 500 000 women 
every year – a cause of death now almost unheard-of in 
high-income countries (HICs). A Canadian woman’s 
lifetime risk of dying from complications of pregnancy 
or childbirth is 1 in 11 000. For a woman in Niger, one 
of the world’s poorest countries, it is 1 in 7 and for the 
developing world as a whole 1 in 76 (Say et al., 2007).
This is one example among many of the health 
contrasts between rich and poor worlds. Average 
life expectancy at birth (LEB) worldwide has been 
estimated at 28.5 years in 1800, much of the short 
average lifespan caused by high rates of death in the 
early years of life. By the end of the twentieth century, 
worldwide average LEB had increased to roughly 67 
years (Riley, 2005), due in large measure to reductions 
in infant and child mortality. However, global pro-
gress conceals large variations between countries. For 
example, Canadians born today can expect to live to 
the age of 80, a figure that is among the world’s high-
est. In countries classified by the World Bank as low-
income, where nearly a billion of the world’s people 
live, estimated LEB averages 59 years. In Zambia, one 
of several such countries ravaged by the AIDS epi-
demic, LEB has dropped to 45 years from a peak of 
more than 50 years in the 1980s (World Bank, 2009, 
accessed December 14, 2009).
Differences in the prevalence of specific dis-
eases are even more dramatic. Although AIDS was 
first identified in HICs, more than 95% of new HIV 
infections now occur outside those countries, with 
the highest prevalence rates in sub-Saharan Africa, 
accounting for two-thirds of the world’s infected 
population and an estimated 1.4 million of the 2.0 
million annual deaths from AIDS (UNAIDS, 2009). 
Malaria and tuberculosis have been almost entirely 
vanquished in HICs. Elsewhere in the world they 
continue to kill almost a million and more than 1.7 
million people per year, respectively (United Nations, 
2009), despite the demonstrated effectiveness of rela-
tively low-cost solutions.1 Health disparities between 
rich and poor countries involve not only differences in 
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the kinds of illnesses that affect their populations, but 
also the ages at which illness and death occur. Of the 
49.4 million deaths in low- and middle-income coun-
tries (LMICs) in 2002, 21% occurred among children 
under 5 years of age; in the HICs, of 7.9 million deaths 
in the same year, just 1% occurred among children 
under 5 (Mathers, 2010). Although the worldwide 
statistical risk of child death declined steadily through 
the last decades of the twentieth century, far more 
substantial gains could have been achieved. In 2006 
nearly 10 million children died before reaching the 
age of 5. All but 100 000 of these deaths occurred out-
side the industrialized countries, most of them from 
causes that are either extremely uncommon in those 
countries or rarely result in death there (Bryce et al., 
2005b; UNICEF, 2008b). Figures 2.1 and 2.2 show the 
far higher overall death rate among both children and 
adults outside HICs, but also the difference in causes 
of death.
Deprivation and economic gradients
The intuitive and largely accurate explanation for 
these differences involves poverty and material 
deprivation. On the best available estimates more 
than a billion people in the world were chronically 
undernourished as of 2009 (United Nations Food and 
Agriculture Organization, 2009); this figure refers 
only to long-term insufficiency of caloric intake, and 
not to a variety of micronutrient deficiencies some of 
which are even more widespread. According to one 
WHO estimate, underweight and other nutritional 
risk factors, including “suboptimal” breastfeeding, 
“were together responsible for an estimate 3.9 mil-
lion deaths” in children under 5, and “[i]n low-income 
countries, easy-to- remedy nutritional deficien-
cies prevent 1 in 38 newborns from reaching age 5” 
(World Health Organization, 2009a, p. 13). This is a 
substantial underestimate of the overall contribution 
of inadequate nutrition to illness, since (for example) 
maternal undernutrition during pregnancy affects 
the health status of mothers as well as their children, 
and undernutrition almost certainly increases adult 
vulnerability to HIV infection and to a range of other 
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Figure 2.1 Annual deaths per 1000 infants and children (age < 5) by WHO region and major cause of death, with all high-income countries 
grouped separately.
Source: World Health Organization, Global Burden of Disease 2004 Update: Selected figures and tables (Powerpoint slides); www.who.int/
entity/healthinfo/global_burden_disease/GBD2004ReportFigures.ppt. Used with permission.
world. However, the spread of those strains is itself 
largely attributable to a history of inadequate provision 
of the resources necessary for vaccination and treatment 
using first-line drugs in LICs (Coker, 2004).
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communicable diseases, as well as exacerbating their 
effects (Bates et al., 2004; Stillwaggon, 2006).
Economic deprivation creates situations in which 
the daily routines of living are themselves hazardous. 
Charcoal or dung smoke from cooking fires is a major 
contributor to respiratory disease among the world’s 
poor (Ezzati & Kammen, 2002). In the fast-growing 
cities of the developing world close to a billion people 
now live in slums, as defined by UN Habitat, with 
resulting exposure to multiple environmental haz-
ards (Unger & Riley, 2007); the number will increase 
to 1.4 billion in 2020 in the absence of effective policy 
interventions (Garau et al., 2005). Lack of access to 
clean water is a major contributor to infectious diar-
rhea and a variety of parasitic diseases (Prüss-Üstun 
et al., 2008), yet an estimated 1.1 billion people lack 
access to clean water and 2.6 billion have no access 
to basic sanitation (United Nations Development 
Program, 2006). A further dimension of the role of 
material deprivation involves the lack of resources to 
access health care. At the individual level, the need to 
pay for health care pushes an estimated 100 million 
people into poverty every year (van Doorslaer et al., 
2006; Xu et al., 2007); at the national level, many low-
income countries (LICs) are simply unable to mobil-
ize the resources needed for minimal health care 
from domestic sources. Ironically, both dynamics 
have often been worsened by health sector “reforms” 
actively promoted by high-income countries (Lister & 
Labonté, 2009).2
In many respects, then, the words of the folk 
song “All My Trials” (made famous by Joan Baez) 
ring true: living is a thing that money can buy; the 
rich do live, and the poor do die. In addition to such 
national differences, socioeconomic gradients in 
health status – inverse correlations between health 
status and various indicators of socioeconomic sta-
tus – are almost universal within national and sub-
national boundaries, in countries rich and poor 
alike. Figure 2.3 shows such gradients in mortality 
among children under 5 (U5MR): children in the 
poorest fifth of the population in five largely dissimi-
lar developing countries are at least twice as likely to 
die before their fifth birthday, and sometimes three 
times as likely, as children in the richest fifth. In India 
alone 1.4 million child deaths would be prevented 
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Figure 2.2 Annual deaths per 1000 adults (age 15–59) by WHO region and major cause of death, with all high-income countries grouped 
separately.
Source: World Health Organization, Global Burden of Disease 2004 Update: Selected figures and tables (Powerpoint slides); www.who.int/
entity/healthinfo/global_burden_disease/GBD2004ReportFigures.ppt. Used with permission.
2 We recognize the importance of poor governance 
(including corruption) and low public spending on 
health in many LMICs, which compound the problems 
of medical poverty and inadequate health-care coverage; 
at the same time, these dynamics cannot be separated 
from those of globalization discussed later in this 
chapter.
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each year if U5MR for the entire Indian population 
were reduced to the level characteristic of its rich-
est quintile (Commission on Social Determinants of 
Health, 2008, p. 29).
Socioeconomic gradients reflect not only daily 
conditions of life and work, but also economic influ-
ences on access to health services: for example, 
dramatic income-related disparities are observed 
in access to the skilled birth attendance that is 
critical to reducing maternal mortality and avoid-
ing postpartum complications (UNICEF, 2008a). 
Socioeconomic gradients are widespread in high-
 income countries, as well. The “eight Americas” study 
in the USA, where racial and economic inequalities 
tend to be superimposed on one another, found 
that the life expectancy of African–Americans in 
“high-risk” urban counties is almost 9 years shorter 
than that of the mostly white residents of “Middle 
America” (Murray et al., 2006). In the words of the 
authors, “tens of millions of Americans are experi-
encing levels of health that are more typical of 
 middle-income or low-income developing countries” 
(Murray et al., 2006, p. 9). This point was empha-
sized in a famous study (McCord & Freeman, 1990) 
that found young men in Harlem, an overwhelm-
ingly African–American area of New York City, had 
a lower LEB than the national average for men in 
Bangladesh. Within individual metropolitan areas 
of the USA and the UK, even larger health disparities 
than those found in the eight Americas study can be 
observed between rich and poor districts: close to 20 
years in Chicago and Washington, DC and 28 years 
in Glasgow (Wang, 1998; Commission on Social 
Determinants of Health, 2008, pp. 31–32).
Growth (and wealth) are not enough
Discussions of global health ethics must avoid the sim-
plistic leap from this set of observations to the conclu-
sion that greater wealth through economic growth is 
the surest route to better health – and, therefore, that 
improvements in population health are best achieved 
by policies that promote economic growth. Superficial 
support for the growth → wealth → health causal path-
way comes from a widely cited graph known as the 
Preston curve, after the economist who first drew it 
(Figure 2.4 shows the curve for the year 2000). The 
graph represents most of the world’s countries with a 
circle, the area of which is proportional to the size of the 
country’s population. The vertical axis shows average 
life expectancy at birth, and the horizontal axis shows 
the country’s Gross Domestic Product (GDP) per cap-
ita, adjusted for purchasing power. The trend line on 
the graph shows the national average life expectancy 
that would be anticipated at a given level of GDP per 
capita, based on a population-weighted average of all 
the national data. The graph shows strong returns to 
economic growth in terms of LEB at low per capita 
incomes, up to about US$5000. Above that point, only 
a weak and inconclusive relation between LEB and 
300
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Figure 2.3 Under-5 mortality by 
income quintile, selected countries, 
c. 2000.  
Source: Data from Gwatkin et al. (2007).
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wealth is evident.3 However, wide variations exist in 
LEB among countries with comparable levels of GDP/
capita. For example, in 2007 LEB in the USA, with a 
Gross National Income (GNI)/capita4 of more than 
$45 000 was 78 years; it was also 78 years in Chile and 
79 in Costa Rica, countries with GNI/capita of $12 280 
and $10 510, respectively. Conversely, some countries 
do far less well in terms of LEB than one might expect 
given their income levels. The most conspicuous out-
liers in this respect are countries in sub-Saharan Africa 
where life expectancy has been drastically reduced by 
the AIDS epidemic. Thus, LEB in Zambia of 45 years 
in 2007 – a figure comparable to LEB in England in 
the 1840s – was more than 20 years lower than that in 
Bangladesh, a comparably poor country but one where 
AIDS is not a substantial contributor to the burden of 
disease; LEB in South Africa and Burundi was 50 years, 
despite the fact that South Africa’s GNI/capita was 
25 times Burundi’s. Indeed, one of Preston’s original 
conclusions was that “[f]actors exogenous to a coun-
try’s level of income probably account for 75–90% of 
the growth in life expectancy for the world as a whole 
between the 1930s and the 1960s. Income growth per 
se accounts for only 10–25%” (Preston, 2007, p. 486; 
original publication 1975).
Medical advances and political choices
Two sets of factors explain much of the remainder. The 
first set comprises advances in medical treatment and 
preventive health measures: antibiotics, immuniza-
tion, pesticides and bed-nets to limit exposure to mos-
quitoes that transmit malaria. In other words, the trend 
line of the Preston curve moves upward on the graph 
over time.5 The second set of factors involves the 
extent to which countries use their available resources 
in ways that result in widely shared improvements in 
health status for their populations – including access to 
advances in treatment and prevention. At the high end 
of the national income spectrum, the USA not only is 
characterized by high and rising disparities in health 
status (Braveman & Egerter, 2008) but also under-
performs in terms of national average LEB because of 
such inter-related phenomena as high homicide rates, 
high and rising rates of poverty and economic inequal-
ity, and a substantial proportion of its population that 
lacks health insurance. Conversely Sri Lanka, Costa 
Rica and the Indian state of Kerala are often cited as 
overperformers in population health status despite low 
GNI/capita and because of their provision of accessible 
primary health care and other social protection meas-
ures (Halstead et al., 1985; Riley, 2008).
Based on such examples Deaton (2006, p. 3) con-
cludes that: “Economic growth is much to be desired 3 The same is not necessarily true for more nuanced indi-
cators of health status such as chronic disease prevalence 
or limited functioning as a result of work-related disabil-
ity (to give but two examples); mortality-based indicators 
are intrinsically crude.
4 GNI is a measure now widely used in preference to GDP. 
All figures cited are adjusted for purchasing power.
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Figure 2.4 The Preston curve for the 
year 2000. Reproduced with the permis-
sion of the author and the American 
Economics Association, from Deaton 
(2003, p. 116).
5 Readers can observe an animated demonstration of 
this effect, and of many of the variations discussed in 
this section of the chapter, in a graph generated on the 
Gapminder web site (http://tinyurl.com/ye7vhyb).
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because it relieves the grinding material poverty of 
much of the world’s population. But economic growth, 
by itself, will not be enough to improve population 
health, at least in any acceptable time … As far as health 
is concerned, the market, by itself, is not a substitute for 
collective action.” That collective action pertains not 
only to the second set of factors (how countries allo-
cate resource priorities and distribution), but also to 
the first set of factors (publicly financed or supported 
innovations in health knowledge, technology and 
global diffusion). Deaton points out that most health 
innovations that contributed to the global convergence 
in health in the last half of the last century, which has 
now been replaced by divergence (Moser et al., 2007), 
originated in wealthier countries. “In this sense, the 
first world has been responsible for producing the 
global public goods of medical and health-related 
research and development from which everyone 
has benefited, in poor and now-rich countries alike” 
(Deaton, 2004, p. 99). In the last 20 years, however, 
companies in high-income countries have led a push 
for worldwide expansion of intellectual property pro-
tection, notably in knowledge-based industries such as 
information technology and pharmaceuticals. This has 
led to the emergence of one of the most contentious 
issues in contemporary global health: that of access to 
essential medicines and other health technologies.
How health risks are distributed
A further complication of the relation between eco-
nomic growth and health involves how growth influ-
ences the nature and distribution of risks to health. It 
was once argued that countries experienced a relatively 
standardized “epidemiological transition” as they grew 
richer, in which infectious or communicable diseases 
(disproportionately affecting children) declined while 
chronic diseases (disproportionately affecting adults) 
increased (Omran, 1971). Although still useful, the 
concept only partially captures a pattern in which 
LMICs are increasingly affected by a “double burden 
of disease,” as persistent or resurgent communicable 
diseases coexist with rapid increases in non-commu-
nicable diseases such as cardiovascular disease, dia-
betes and cancer. Figure 2.2 shows that the combined 
death rate from cardiovascular disease and cancer in 
sub-Saharan Africa is comparable to that in the high-
income countries; their proportional contribution to 
mortality in that region is lower only because of the toll 
taken by other causes of death.
On one estimate, 100 million men in China alone 
will die from smoking-related diseases between 2000 
and 2050 (Zhang & Cai, 2003). Additionally, road 
traffic accidents kill an estimated 1.2 million  people 
a year; WHO projects that the number will  double 
by 2030 given current trends, mostly as a result of 
increases in LMICs (World Health Organization, 
2009b). Ironically, those most likely to be injured are 
the poor, who are least likely to own a vehicle – a dis-
tribution of risks that is sometimes exacerbated by 
planning practices that favor high-speed roads for 
the emerging middle classes. In many cases, addi-
tional hazards are associated with exposures to indus-
trial or motor vehicle pollution and dangers in the 
industrial or agricultural workplace. Birn et al. (2009, 
chapter 6) have suggested that it may be useful to 
replace the familiar categories of communicable and 
non-communicable diseases with a threefold typol-
ogy: diseases of marginalization and deprivation, 
such as diarrhea, neglected tropical diseases, malaria, 
respiratory infections; diseases of modernization and 
work, such as cardiovascular disease, cancer, road 
traffic injuries; and diseases of marginalization and 
modernization, such as diabetes, chronic obstruc-
tive pulmonary disease (COPD), tuberculosis, HIV/
AIDS. Socioeconomic gradients are observable with 
respect to all three categories of disease, includ-
ing those widely regarded as “diseases of affluence” 
(Ezzati et al., 2005).
The significance of the double burden of disease 
concept is illustrated by the coexistence of undernu-
trition with rapid growth of overweight and obesity in 
LMICs: indeed, in some instances, of undernutrition 
and overnutrition in the same household (Popkin, 
2002). Reflecting a “nutrition transition” involving a 
rapid shift to diets higher in fats, caloric sweeteners 
and meat coupled with reductions in physical activ-
ity (Popkin, 2009), overweight and obesity in several 
middle-income countries are approaching the levels 
seen in countries like the USA. An especially strik-
ing study involves a sample of women in regions that 
account for more than 70% of Brazil’s population. In 
1975, almost twice as many Brazilian women were 
underweight as were obese; by 1997, the proportions 
had reversed, with the increases in obesity concen-
trated among low-income women (Monteiro et al., 
2004). The emergence of this socioeconomic gradient 
is a broader trend in Brazil (Monteiro et al., 2007) and 
in many other LMICs (Popkin, 2008).
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An equally disturbing observation is that the 
prevalence of overweight and obesity in many cases 
is increasing far more rapidly than it did in the high-
 income countries decades earlier (Popkin, 2006), 
 setting the stage for future increases in cardiovascular 
disease and diabetes that will widen existing health dis-
parities. These developments, in turn, must be under-
stood with reference to urbanization and its effects 
on dietary choices and physical activity (Mendez & 
Popkin, 2004) and various aspects of globalization. The 
lowering of barriers to trade and cross-border invest-
ment has facilitated consolidation of power over food 
systems in the hands of supermarkets at the top of glo-
bal commodity chains; led to increased foreign direct 
investment in supermarkets and fast-food chains; and 
lengthened the reach of transnational marketing cam-
paigns featuring brands such as McDonald’s and Coca-
Cola (Hawkes, 2005; Hawkes et al., 2009). Mexicans 
are now the world’s leading consumer of Coca-Cola 
products, drinking roughly 50% more per person than 
people in the USA (The Coca-Cola Company, 2009).
Globalization, markets and health  
in an unequal world
Globalization, defined here as “[a] pattern of trans-
national economic integration animated by the ideal 
of creating self-regulating global markets for goods, 
services, capital, technology, and skills” (Eyoh & 
Sandbrook, 2003), presents broader challenges as well, 
starting with the “inherently disequalizing” character 
of global markets (Birdsall, 2006): they reward those 
countries, and economic elites within them, already 
well endowed with financial assets and economically 
productive factors while operating according to rules 
that are shaped to magnify these advantages.
The first dynamic is exemplified by the fact that 
hedge fund managers, the quintessential players on 
global financial markets, now draw multibillion-dollar 
annual incomes (Taub, 2008) against a background of 
only modest reductions in global poverty rates over 
three decades during which the value of the world’s 
economic product quadrupled (Chen & Ravallion, 
2008). Descriptions of global economic inequality tend 
to be highly abstract; Figure 2.5 is a visual presentation 
of the distribution of income within and among the 
world’s countries. In Figure 2.5, countries are allocated 
a number of rows of columns based on their popula-
tion; so each column represents approximately one 
million of the world’s people. Countries are ordered 
from poorest to richest along the left-to-right axis; for 
each 10 million people, income is ordered in deciles 
(10 columns of one million each) along the front-to-
back axis. The vertical axis shows income per capita, 
after adjustment for purchasing power. Although 
intracountry income disparities are large even in some 
countries that are relatively poor as ranked by income 
per capita – an internal disparity that would be far 
more dramatic if we could visually depict, say, the top 
1% or 0.1% of income earners in each country – the 
commanding heights of the worldwide income distri-
bution are occupied by rich people in rich countries. 
“In 2005 [when the original version of this graph was 
published] the top one-tenth of US citizens [received] 
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Figure 2.5 Global income distribu-
tion: the world is not flat. Annual 
income (adjusted for purchasing 
power parity) by income decile, 140 
countries, 2008.
Source: Graph generated by 
Bob Sutcliffe © 2009. Used with 
permission.
 
 
2. The state of global health in a radically unequal world
31
a total income equal to that of the poorest 2 200 000 000 
citizens in the world” (Sutcliffe, 2005, p. 12). Wealth is 
more concentrated than income, within countries and 
globally (Davies et al., 2008), and as noted the tendency 
of global markets is to increase the concentration of 
both; this tendency is not beyond the ability of national 
policies to reverse, although efforts to do so often con-
front formidable domestic opposition.
Birdsall’s second dynamic is illustrated by the 
development of a multilateral trade regime with intel-
lectual property provisions driven by the interests of 
major US pharmaceutical and information technol-
ogy corporations (Sell, 2003), and the rise in bilat-
eral “strong-arming” negotiations to increase access 
to developing country markets given the slow pace of 
negotiations in multilateral trade talks (where develop-
ing countries have more combined bargaining power). 
More generally, and as noted in other chapters in this 
volume, globalization as it has emerged over the past 
few decades was actively promoted by the governments 
of major G7 powers, acting on their own and through 
multilateral institutions like the World Bank and the 
International Monetary Fund (IMF); by transnational 
corporations that now routinely reorganize produc-
tion across multiple national borders; and by owners of 
financial assets who can now shift them across national 
borders in search of higher returns and lower risks, 
often destabilizing national economies and plunging 
millions into poverty as a result.6 In many cases, not-
ably the structural adjustment programs demanded by 
the World Bank and IMF as the condition for loans that 
would enable governments to maintain their ability to 
borrow on international markets, the results included 
increased economic inequality and a decline in the abil-
ity of governments to meet basic health-related needs. 
Such measures generated social and economic condi-
tions that may have contributed to the spread of HIV 
infection in Africa (De Vogli & Birbeck, 2005). Similar 
economic “shock therapy,” applied to the former Soviet 
Union, contributed to economic decline that reduced 
male life expectancy, in particular, as GDP shrank by 
roughly 50% with drastic increases in poverty and eco-
nomic inequality (Field et al., 2000). If health was con-
sidered at all in such macroeconomic prescriptions, it 
was on the basis described by a team of World Bank 
economists writing about the former Soviet Union and 
its Eastern European satellites: that “In the long run, 
the transition towards a market economy and adop-
tion of democratic forms of government should ultim-
ately lead to improvements in health status … In the 
short run, however, one could expect that health sta-
tus would deteriorate” (Adeyi et al., 1997, p. 133). As 
in other cases, the anticipation of long-term gains is 
better understood as an expression of faith than as an 
evidence-based assessment.
As an empirical test of the performance of global-
ization in delivering health benefits over the first two 
decades (1980–2000) of intensified economic inte-
gration, Cornia and colleagues (2008) carried out an 
innovative econometric exercise based on data from 
136 countries in which they first identified five main 
influences on mortality: (i) material deprivation; (ii) 
psychological stress; (iii) unhealthy lifestyles; (iv) 
inequality and lack of social cohesion; and (v) medical 
progress: the variable identified by Preston and Deaton 
as the primary influence on worldwide life expectancy 
during an earlier period. They then described a range of 
variables that affect these influences, classifying them 
as either (a) related to policy choices made in the con-
text of globalization (e.g. income inequality, immun-
ization rates); (b) endogenous, and therefore unrelated 
to globalization for purposes of the analysis (medical 
progress); or (c), describable as “shocks” (e.g. wars 
and natural disasters, HIV/AIDS). The final stage of 
their analysis consisted of a simulation that compared 
trends in LEB over the period 1980–2000 with those 
that would be predicted based on a counterfactual set 
of assumptions in which trends in all the relevant vari-
ables did not follow the actual 1980–2000 pattern, but 
rather remained at the 1980 value or continued the 
trend they followed over the pre-1980 period. Thus, it 
was assumed in the counterfactual (for instance) not 
only that income distribution within countries, one of 
the globalization-related variables, did not change over 
the period 1980–2000, but also that there was no pro-
gress in medical technology and that HIV incidence 
remained at its 1980 level.
This simulation indicated that, on a worldwide 
basis over the period 1980–2000, (a) globalization can-
celled out most of the progress toward better health 
(as measured by LEB) attributable to the diffusion of 
medical progress, and (b) the effects of shocks (wars, 
natural disasters and AIDS) combined with globaliza-
tion resulted in a slight worldwide decline in LEB as 
6 Due to space limitations, we are unable to provide 
citations to the extensive social science literature on the 
global marketplace. Readers are referred to our earlier 
published work, in particular Labonté & Schrecker, 
(2007) and Labonté et al. (2009).
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compared with the counterfactual. Globalization’s 
most conspicuous effects on LEB occurred in the tran-
sition economies and the former Soviet Union (where 
globalization accounted for essentially the entire 
decline) and sub-Saharan Africa (where globalization 
contributed almost as much as the AIDS epidemic). 
Although data limitations mean that “the establish-
ment of a causal nexus between globalization policies 
and health cannot be but tentative” (Cornia et al., 2008, 
p. 1), the study nonetheless represents a remarkable 
rebuttal of claims about globalization’s health ben-
efits to date, notably including the performance of the 
“growth superstars,” India and China (Cornia et al., 
2008, p. 31). Its authors emphasize that “the negative 
association noted between liberalization-globalization 
policies, poor economic performance and unsatisfac-
tory health trends … seems to be quite robust” (Cornia 
et al., 2008, p. 36).
Long-term benefits?
It can always be argued that the longer-term benefits 
of integration into the global marketplace have simply 
yet to materialize; growth should eventually gener-
ate resources to improve health for all. But against the 
background of lost development progress that followed 
the financial crisis of 2008 (World Bank & International 
Monetary Fund, 2009, chapter 1), this might be called 
the Waiting for Godot approach to population health. 
Even before the crisis, the issue identified in passing 
by Deaton was an urgent one from an ethical point of 
view: how long should the majority of the world’s people 
be asked to wait for the presumed benefits of globaliza-
tion to reach them? As Thomas Pogge has pointed out 
in his important work on poverty and global justice, it 
is not difficult to envision alternative sets of economic 
and political institutions that would not involve long 
periods of pain in anticipation of health gains at some 
indeterminate point in the future (Pogge, 2002, 2007). 
A focus on the institutions of the global marketplace 
is also necessary because – although the point cannot 
be pursued further here – globalization has probably 
created major obstacles to countries wishing today 
to emphasize widely shared improvements in human 
welfare and the redistributive policies that bring these 
about. Foreign investors and the purchasers at the top 
of global commodity chains for manufactured products 
demand cost containment and “flexible” labor regimes; 
a liberalized financial marketplace facilitates capital 
flight in anticipation of higher taxation; and trade poli-
cies limit countries’ ability to favor domestic producers 
while enforcing intellectual property protections, few 
of which existed when the high-income countries were 
starting their path to riches.
Prospects for the future:  
money matters
Despite the uncertainties created by globalization, 
some efforts to improve the health status of people 
outside the metaphorical castle walls have succeeded 
in recent years. Improvements in vaccination coverage 
have reduced measles deaths from more than 700 000 
in 2000 to an estimated 164 000 in 2008 (Dabbagh 
et al., 2009). At the end of 2008, 4 million people were 
receiving antiretroviral therapy for AIDS in low- and 
 middle-income countries, a tenfold increase over 
7 years, although still a long way from WHO’s stated 
goal of universal coverage (World Health Organization, 
UNAIDS & UNICEF, 2009). Conversely, despite abun-
dant evidence on the effectiveness and cost of the rele-
vant interventions, only limited progress has been 
made in reducing maternal mortality – within the lim-
its of available data, none in sub-Saharan Africa, where 
it is highest (United Nations, 2009) – and progress in 
reducing child mortality remains far inferior to what 
could have been achieved based on available evidence 
(Bryce et al., 2005a). An extensive list exists of demon-
strably effective interventions to improve maternal and 
child health (Bryce et al., 2005b; Bhutta et al., 2008). 
Meeting the challenge of improving the availability 
of these interventions will require strengthening the 
public-sector health systems that are essential to deliver 
them. This is a formidable task, particularly since it 
often entails not only addressing the “brain drain” of 
health professionals from LICs but also, more gener-
ally, repairing damage done by long periods of under-
funding that were driven in part by the imperatives of 
globalization.
Although detailed analysis is beyond the scope of 
this chapter, the success stories cited in the preceding 
paragraph depended on effective and sustained mobil-
ization of financial and other resources, both domes-
tically and internationally. Apprehensions are being 
expressed about the availability of resources to continue 
these initiatives in the future (Dabbagh et al., 2009), 
with one US commentator referring to antiretroviral 
therapy as a “ballooning entitlement burden” (Over, 
2008). According to recent estimates, the value of all 
public development assistance for health increased 
from $4.15 billion in 1990 to $14.08 billion in 2007 
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(Ravishankar et al., 2009). By contrast, one assessment 
of the need for such assistance is based on estimates 
by the World Health Organization’s Commission on 
Macroeconomics and Health of the cost of financing 
basic health care and preventive interventions in all 
LICs: $40/person/year, in 2007 dollars (Sachs, 2007a). 
Even if all the world’s low-income countries were to 
commit 15% of their general government expendi-
tures to health – and many governments’ spending on 
health is well below that figure – annual spending of 
$28–36 billion by the high-income countries would be 
necessary to provide a “global social health protection 
floor” (Ooms, 2009). Factually, this approach recog-
nizes the implausibility of insisting that health systems 
in LICs can be financed primarily from domestic rev-
enues in the near future (Sachs, 2007b). Normatively, 
this approach is a direct challenge to the “entitlement 
burden” view of financing health protection outside 
the high-income countries. This figure, however, rep-
resents only part of the resources needed to support 
widely shared improvements in population health – 
for example, by investing in the provision of safe 
drinking water, sanitation, and slum upgrading. Still 
less would such a commitment satisfy the critical need, 
identified by the Commission on Social Determinants 
of Health (2008, see generally chapters 3, 11 and 15), 
for “changes in the functioning of the global economy” 
that would redress the unequal distribution of power 
and resources that it identified as a fundamental cause 
of ill health.
Rather, the figure is cited here to make two points 
by way of conclusion. First, money matters, and global 
health ethics must start from the position that rhetoric 
is no substitute for commitments of resources to pro-
tect health on a much larger scale than at present. This 
can serve as a point of agreement even among research-
ers and practitioners who disagree about the relative 
value of improving social determinants of health and 
those who emphasize the “upstream” social determi-
nants of health, usually with a focus on poverty and 
economic inequality, and those who dismiss interven-
tions to address these factors as “romantic but imprac-
ticable notions” (Jha et al., 2005), arguing instead for a 
focus on biomedical innovations and scaling up health 
systems. In fact, all of these are necessary, with the rela-
tive importance depending on context: no amount of 
investment in health systems will undo the damage 
caused by indoor air pollution from cooking smoke; no 
investment in social determinants of health will substi-
tute for the skilled birth attendance that is essential to 
reducing maternal mortality; and neither problem can 
be addressed without real resources.
Second, in today’s global environment a preoccu-
pation with setting priorities in “resource-constrained” 
contexts is a diversion (Schrecker, 2008). In addition 
to providing a harsh demonstration of the vulnerabil-
ities created by globalization, the financial crisis that 
swept across the world in 2008 emphasized a point that 
Jeffrey Sachs has been making for years: “in a world of 
trillions of dollars of income every year,” the resources 
needed to address emergencies of the kind described in 
our introductory paragraph are available (Sachs, 2003). 
Pogge has often made a similar point in the context of 
global poverty. The fact that resource scarcities con-
demn millions every year to premature and avoidable 
deaths, and millions more to shorter and less healthy 
lives than most readers of this volume take for granted, 
must be understood as policy-generated, resulting 
from choices that could have been made differently and 
institutions that can function differently.
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